Teriparatide
Shop Teriparatide
Shop TeriparatideCode ths10 applied at checkout
Also called: Teriparatide plus zoledronic acid sequential treatment, Teriparatide followed by Zoledronic Acid (TOPaZ Trial Protocol), Teriparatide plus Zoledronic Acid
By The Health Stacks Research TeamUpdated September 20, 2026
The pages you shared talk about peptides in general, but they do not really talk about Teriparatide. Teriparatide is a medicine, not a supplement. It is a copy of a natural body signal that helps build bone. Doctors use it for weak, thin bones that break easily.
Peptides are tiny chains of building blocks called amino acids. Some peptides, like medicines that help with blood sugar, copy signals your body already uses. Teriparatide works this way too. It copies a natural hormone signal and tells your bones to grow stronger instead of weaker.
Because these pages do not give details about Teriparatide itself, much is missing here. Some peptides sold online are not tested or safe, and doctors warn people not to inject things without a doctor. Always talk to a real doctor before using any peptide medicine.
ApprovedApproved by a regulator (e.g. FDA) for a specific medical use — the highest research-status tier. High confidence60–79 — backed by solid sources with good corroboration across multiple citations.
Benefits
What Teriparatide Helps With
The benefits people report — backed by research.
Musculoskeletal (11)
Bone repair 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 2 srcTreats osteoporosis in postmenopausal women at high risk for fractures 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Treats corticosteroid-induced osteoporosis in men and women at high risk for fractures 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Treatment of Medication-Related Osteonecrosis of the Jaw 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Reduces fracture risk 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Inhibits RANKL to reduce osteoclast activity 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Reduces risk of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Treatment of osteoporosis associated with sustained systemic glucocorticoid therapy 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Alternative treatment for osteoporosis in patients who cannot take bisphosphonates or do not respond to them 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →First-line anabolic therapy for very high fracture risk osteoporosis 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Promotes osteoblast differentiation 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →
Performance & recovery (3)
Improves select quality-of-life measures including BPI interference and EQ-5D-3L scores 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Favored in several quality-of-life measures compared to standard care 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Sequential therapy followed by bisphosphonate or denosumab after anabolic use 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →
Cardiovascular & vascular (2)
Angiogenesis 70/100Rated 70/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Vasodilation 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →
More reported benefits (4)
Parathyroid hormone replacement 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Bone repair 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Anti-inflammatory 80/100Rated 80/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Transdermal HRT improves lumbar spine and femoral neck BMD in functional hypothalamic amenorrhea 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →
Free: The Peptide Stack Cheat-Sheet
You just read the research on Teriparatide. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
How People Use It
1 reported routine — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
- 20μg 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Safety
Known Side Effects
Adverse effects reported in the research and by community use.
- Orthostatic hypotension (fast heartbeatModerate 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medlineplus.gov
- Injection site reactions (redness, pain, swelling, bruising, blood drops, or itching)Mild 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medlineplus.gov
- Leg crampsMildReported in 4 sources 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medlineplus.gov↗ bonehealthandosteoporosis.org↗ bonehealthandosteoporosis.org↗ peptide-db.com
- Nausea and vomitingModerate 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medlineplus.gov
- Chest painSevere 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medlineplus.gov
- Difficulty breathingSevere 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medlineplus.gov
- DizzinessModerate 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medlineplus.gov
- lightheadednessModerate 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medlineplus.gov
- and fainting when getting up quickly)Moderate 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medlineplus.gov
- Rapid increase in bone loss after discontinuationSevere 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medscape.com
- Loss of effects after discontinuationModerate 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medscape.com
- Loss of bone density gains after discontinuationModerate 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medscape.com
- Rapid increase in bone loss following Denosumab discontinuationModerate 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ medscape.com
- PainMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ reference.medscape.com
- ArthralgiaMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ reference.medscape.com
- NauseaMildReported in 4 sources 72/100Rated 72/100Source typeEstablished referenceIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ reference.medscape.com↗ bonehealthandosteoporosis.org↗ bonehealthandosteoporosis.org↗ peptide-db.com
- DizzinessMildReported in 2 sources 72/100Rated 72/100Source typeEstablished referenceIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ reference.medscape.com↗ peptide-db.com
- HeadacheMildReported in 5 sources 72/100Rated 72/100Source typeEstablished referenceIndependent sources5Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ reference.medscape.com↗ theros.org.uk↗ bonehealthandosteoporosis.org↗ bonehealthandosteoporosis.org+1
- Hypercalcemia (>13 mg/dL)Moderate 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ reference.medscape.com
- Orthostatic hypotensionModerate 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ reference.medscape.com
- OsteosarcomaSevere 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ reference.medscape.com
- CalciphylaxisSevere 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ reference.medscape.com
- Injection site reactionsMildReported in 2 sources 72/100Rated 72/100Source typeEstablished referenceIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ reference.medscape.com↗ peptide-db.com
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Get Teriparatide
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Shop Teriparatide
Code ths10 applied at checkout
Evidence
Research Citations (1)
Every claim above traces back to a source you can check — here are 1 of them.
- Source
Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial.
95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
Timeline
History & Milestones
Key moments in Teriparatide’s research and regulatory timeline — sourced and dated.
- Teriparatide – Indications beyond osteoporosisPublicationMay 1, 2012Related:Teriparatide
News
Latest on Teriparatide
Dated, sourced reporting that mentions Teriparatide.
Wondering how Teriparatide pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →